7-41967848-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000168.6(GLI3):​c.2179G>A​(p.Gly727Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00635 in 1,614,096 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G727G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0051 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 51 hom. )

Consequence

GLI3
NM_000168.6 missense

Scores

5
7
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:10

Conservation

PhyloP100: 5.65

Publications

34 publications found
Variant links:
Genes affected
GLI3 (HGNC:4319): (GLI family zinc finger 3) This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI3 Gene-Disease associations (from GenCC):
  • Greig cephalopolysyndactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
  • Pallister-Hall syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics, Orphanet
  • polydactyly, postaxial, type A1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • polysyndactyly 4
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • tibial hemimelia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acrocallosal syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postaxial polydactyly type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008583009).
BP6
Variant 7-41967848-C-T is Benign according to our data. Variant chr7-41967848-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 13821.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00506 (771/152228) while in subpopulation NFE AF = 0.00819 (557/68018). AF 95% confidence interval is 0.00763. There are 2 homozygotes in GnomAd4. There are 382 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI3NM_000168.6 linkc.2179G>A p.Gly727Arg missense_variant Exon 14 of 15 ENST00000395925.8 NP_000159.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI3ENST00000395925.8 linkc.2179G>A p.Gly727Arg missense_variant Exon 14 of 15 5 NM_000168.6 ENSP00000379258.3

Frequencies

GnomAD3 genomes
AF:
0.00508
AC:
772
AN:
152110
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00415
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00820
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00527
AC:
1325
AN:
251488
AF XY:
0.00556
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00762
Gnomad NFE exome
AF:
0.00755
Gnomad OTH exome
AF:
0.00521
GnomAD4 exome
AF:
0.00649
AC:
9484
AN:
1461868
Hom.:
51
Cov.:
32
AF XY:
0.00660
AC XY:
4797
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33480
American (AMR)
AF:
0.00174
AC:
78
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00272
AC:
71
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00579
AC:
499
AN:
86256
European-Finnish (FIN)
AF:
0.00766
AC:
409
AN:
53420
Middle Eastern (MID)
AF:
0.00676
AC:
39
AN:
5768
European-Non Finnish (NFE)
AF:
0.00722
AC:
8033
AN:
1111988
Other (OTH)
AF:
0.00528
AC:
319
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
547
1094
1640
2187
2734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00506
AC:
771
AN:
152228
Hom.:
2
Cov.:
32
AF XY:
0.00513
AC XY:
382
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41536
American (AMR)
AF:
0.00190
AC:
29
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00375
AC:
13
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00436
AC:
21
AN:
4818
European-Finnish (FIN)
AF:
0.0107
AC:
113
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00819
AC:
557
AN:
68018
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00634
Hom.:
13
Bravo
AF:
0.00392
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00767
AC:
66
ExAC
AF:
0.00571
AC:
693
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.00665
EpiControl
AF:
0.00735

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 10441570, 25527561, 31325247, 32696176) -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLI3: BS2 -

Apr 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 28, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Postaxial polydactyly, type A1/B Uncertain:1
Sep 01, 1999
OMIM
Significance:Uncertain significance
Review Status:flagged submission
Collection Method:literature only

- -

Pallister-Hall syndrome;C0265306:Greig cephalopolysyndactyly syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Postaxial polydactyly Benign:1
Dec 10, 2023
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Greig cephalopolysyndactyly syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Polydactyly Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pallister-Hall syndrome Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.060
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.87
D;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.93
D;D
MetaRNN
Benign
0.0086
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
5.6
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-7.3
D;.
REVEL
Uncertain
0.47
Sift
Uncertain
0.013
D;.
Sift4G
Benign
0.092
T;.
Polyphen
0.99
D;.
Vest4
0.94
MutPred
0.79
Loss of glycosylation at S726 (P = 0.0404);.;
MVP
0.87
MPC
1.1
ClinPred
0.036
T
GERP RS
5.8
Varity_R
0.68
gMVP
0.56
Mutation Taster
=88/12
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121917710; hg19: chr7-42007446; COSMIC: COSV67887449; COSMIC: COSV67887449; API